• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL0600050 注射用重组抗IgE人源化单克隆抗体 Lyophilized Biological Products(2) New Drug Application 2006-12-07 上海张江生物技术有限公司 Shanghai Zhangjiang BIOTECHNOLOGY Co Ltd Certificate Issued 2008-02-22 view
CXSL1700097 注射用重组抗IgE人源化单克隆抗体 Lyophilized Biological Products(2) New Drug Application 2017-10-19 海正药业(杭州)有限公司 Hisun Pharmaceutical (Hangzhou) Co Ltd Certificate Issued 2018-10-22 view
CXSL2101079 注射用重组抗IgE人源化单克隆抗体 Lyophilized Biological Products(3.3) New Drug Application 2021-05-18 Shanghai Xiesheng Medical Technology Co Ltd view
CXSL2101178 注射用重组抗IgE人源化单克隆抗体 Lyophilized Biological Products(3.3) New Drug Application 2021-07-12 Shanghai Taiyin Biotechnology Co Ltd view